ALKERMES PLC. (ALKS)
Clinical trial NCT06843590 updates: 1. completion date: 2026-06-01 → 2026-11-01 2. primary completion date: 2026-06-01 → 2026-11-01 3. enrollment: 96 → 126 participants
Clinical trial NCT06843590 updates: 1. completion date: 2026-06-01 → 2026-11-01 2. primary completion date: 2026-06-01 → 2026-11-01 3. enrollment: 96 → 126 participants
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical